Skip to main content
OpenTrials

Clinical trial condition

Kidney Neoplasms

Explore clinical trials studying Kidney Neoplasms. Study availability and eligibility vary by location and protocol.

1,142 public trials 219 recruiting studies
Refine in advanced search Browse all conditions

Kidney Neoplasms trial results

Completed

A Study of INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors

NCT02697591

Conditions
Adenocarcinoma, Advanced Malignancies, Bronchial Neoplasms, +36 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Yale University New Haven, Connecticut, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer

NCT01835158

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Anchorage Oncology Centre Anchorage, Alaska, United States
View all 488 locations
View Trial Details
Completed

A Phase I/II Study to Assess the Safety and Efficacy of TKI258 for the Treatment of Refractory Advanced/Metastatic Renal Cell Cancer

NCT00715182

Conditions
Adenocarcinoma, Advanced/ Metastatic Renal Cell Cancer, Carcinoma, +14 more
Locations
  • Novartis Investigative Site San Francisco, California, United States
  • Novartis Investigative Site Durham, North Carolina, United States
  • Novartis Investigative Site Seattle, Washington, United States
  • Novartis Investigative Site Bordeaux, France
View Trial Details
Completed

Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

NCT01482156

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +20 more
Locations
  • Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States
  • Washington University School of Medicine Washington University (16) St Louis, Missouri, United States
  • Medical University of South Carolina SC Charleston, South Carolina, United States
  • Novartis Investigative Site Wilrijk, Belgium
View Trial Details
Completed

A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer

NCT02082210

Conditions
Adenocarcinoma, Advanced Cancer, Bronchial Neoplasms, +31 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Tennessee Oncology PLLC Nashville, Tennessee, United States
View Trial Details

Related conditions